Gene expression of CDKN2A, CDKN2B, IGF2BP2 and CDKAL1 in diabetic nephropathy patients with TCM syndrome differentiations

He Yongxin,Li Xue,Wu Yuyang,Wang Yiming,Luo Guo-an
DOI: https://doi.org/10.3969/j.issn.1674-3849.2009.03.005
2009-01-01
Abstract:AIM: To study the gene expression of CDKN2A, CDKN2B, IGF2BP2 and CDKAL1 in diabetic nephropathy patients with TCM syndrome differentiations. METHORDS: The mRNA was extracted form blood samples, and cDNA was gained through reverse transcription using the mRNA as a template. Gene expression level was detected by Real-Time PCR method. RESULTS: The quantitative methods for these 4 genes were established, and these 4 genes expression level were detected in 50 cases of normal subject and 53 cases of diabetic nephropathy patients. CONCLUSION: In this study, gene expression of CDKN2A, CDKN2B, IGF2BP2 and CDKAL1 in diabetic nephropathy patients with TCM syndrome differentiations were detected, and the relationship between gene expression and TCM syndrome differentia-tions in DN was studied. Quantitative indicators for clinical diagnosis of DN in TCM were provided, and it also indicated that gene research is significant for clinical diagnosis and treatment of TCM.
What problem does this paper attempt to address?